Patient and provider factors associated with the noninitiation of tamoxifen for young women at high‐risk for the development of breast cancer-Reference-Cited by-同舟云学术

Patient and provider factors associated with the noninitiation of tamoxifen for young women at high‐risk for the development of breast cancer

Published:2020-03 Issue:3 Volume:26 Page:464-468
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Kandagatla Pridvi¹²^ORCID,Rizk Natalie N.¹,Dokic Danijela³,Kochkodan Jeannie⁴,Estevez Samantha⁵,Yanik Megan⁴,Goranta Sowmya⁶,Huber‐Keener Kathryn⁷^ORCID,Jeruss Jacqueline S.¹

Affiliation:

1. Surgery University of Michigan Ann Arbor Michigan

2. Surgery Henry Ford Hospital Detroit Michigan

3. Medicine Mercy Hospital Chicago Illinois

4. University of Michigan School of Medicine Ann Arbor Michigan

5. Ob/Gyn Zucker School of Medicine Hempstead New York

6. Internal Medicine Michigan State University Flint Michigan

7. Ob/Gyn University of Iowa Iowa City Iowa

Funder

Stichting A Sister's Hope

Foundation for the National Institutes of Health

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13528

Reference19 articles.

1. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

2. Breast Cancer Risk Reduction

3. American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition

4. Tamoxifen for women at high risk of breast cancer;Nazarali SA;Breast Cancer (Dove Med Press),2014

5. Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5);Annals of Oncology;2022-11

2. Longitudinal Risk Management for Patients with Increased Risk for Breast Cancer;Journal of Surgical Research;2021-10